RhumbLine Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $507K | Buy |
27,065
+555
| +2% | +$10.4K | ﹤0.01% | 2675 |
|
|
2025
Q1 | $477K | Buy |
26,510
+1,367
| +5% | +$24.6K | ﹤0.01% | 2604 |
|
|
2024
Q4 | $423K | Buy |
25,143
+1,485
| +6% | +$25K | ﹤0.01% | 2776 |
|
|
2024
Q3 | $383K | Sell |
23,658
-1,342
| -5% | -$21.7K | ﹤0.01% | 2885 |
|
|
2024
Q2 | $205K | Buy |
25,000
+1,206
| +5% | +$9.91K | ﹤0.01% | 3208 |
|
|
2024
Q1 | $352K | Buy |
23,794
+809
| +4% | +$12K | ﹤0.01% | 2887 |
|
|
2023
Q4 | $333K | Buy |
22,985
+125
| +0.5% | +$1.81K | ﹤0.01% | 2912 |
|
|
2023
Q3 | $247K | Buy |
22,860
+72
| +0.3% | +$778 | ﹤0.01% | 3039 |
|
|
2023
Q2 | $294K | Buy |
22,788
+400
| +2% | +$5.16K | ﹤0.01% | 3035 |
|
|
2023
Q1 | $296K | Buy |
22,388
+561
| +3% | +$7.42K | ﹤0.01% | 2620 |
|
|
2022
Q4 | $327K | Buy |
21,827
+527
| +2% | +$7.9K | ﹤0.01% | 2646 |
|
|
2022
Q3 | $251K | Buy |
21,300
+2,283
| +12% | +$26.9K | ﹤0.01% | 2811 |
|
|
2022
Q2 | $215K | Buy |
19,017
+682
| +4% | +$7.71K | ﹤0.01% | 2906 |
|
|
2022
Q1 | $548K | Buy |
18,335
+111
| +0.6% | +$3.32K | ﹤0.01% | 2388 |
|
|
2021
Q4 | $483K | Sell |
18,224
-352
| -2% | -$9.33K | ﹤0.01% | 2520 |
|
|
2021
Q3 | $674K | Buy |
18,576
+422
| +2% | +$15.3K | ﹤0.01% | 2416 |
|
|
2021
Q2 | $788K | Sell |
18,154
-1,589
| -8% | -$69K | ﹤0.01% | 2348 |
|
|
2021
Q1 | $675K | Sell |
19,743
-1,304
| -6% | -$44.6K | ﹤0.01% | 2357 |
|
|
2020
Q4 | $737K | Buy |
21,047
+1,214
| +6% | +$42.5K | ﹤0.01% | 2272 |
|
|
2020
Q3 | $476K | Sell |
19,833
-2,769
| -12% | -$66.5K | ﹤0.01% | 2308 |
|
|
2020
Q2 | $414K | Sell |
22,602
-493
| -2% | -$9.03K | ﹤0.01% | 2433 |
|
|
2020
Q1 | $360K | Sell |
23,095
-200
| -0.9% | -$3.12K | ﹤0.01% | 2317 |
|
|
2019
Q4 | $499K | Buy |
23,295
+390
| +2% | +$8.35K | ﹤0.01% | 2361 |
|
|
2019
Q3 | $428K | Buy |
22,905
+59
| +0.3% | +$1.1K | ﹤0.01% | 2403 |
|
|
2019
Q2 | $596K | Buy |
22,846
+1,516
| +7% | +$39.5K | ﹤0.01% | 2285 |
|
|
2019
Q1 | $548K | Sell |
21,330
-483
| -2% | -$12.4K | ﹤0.01% | 2296 |
|
|
2018
Q4 | $502K | Buy |
21,813
+7,149
| +49% | +$165K | ﹤0.01% | 2298 |
|
|
2018
Q3 | $471K | Sell |
14,664
-888
| -6% | -$28.5K | ﹤0.01% | 2302 |
|
|
2018
Q2 | $440K | Buy |
15,552
+2,175
| +16% | +$61.5K | ﹤0.01% | 2358 |
|
|
2018
Q1 | $474K | Buy |
13,377
+1,548
| +13% | +$54.9K | ﹤0.01% | 2234 |
|
|
2017
Q4 | $459K | Sell |
11,829
-2,359
| -17% | -$91.5K | ﹤0.01% | 2267 |
|
|
2017
Q3 | $360K | Buy |
14,188
+207
| +1% | +$5.25K | ﹤0.01% | 2483 |
|
|
2017
Q2 | $382K | Buy |
13,981
+791
| +6% | +$21.6K | ﹤0.01% | 2440 |
|
|
2017
Q1 | $437K | Buy |
13,190
+2,252
| +21% | +$74.6K | ﹤0.01% | 2309 |
|
|
2016
Q4 | $260K | Sell |
10,938
-1,353
| -11% | -$32.2K | ﹤0.01% | 2554 |
|
|
2016
Q3 | $451K | Sell |
12,291
-105
| -0.8% | -$3.85K | ﹤0.01% | 2266 |
|
|
2016
Q2 | $276K | Buy |
12,396
+1,763
| +17% | +$39.3K | ﹤0.01% | 2578 |
|
|
2016
Q1 | $221K | Buy |
10,633
+410
| +4% | +$8.52K | ﹤0.01% | 2691 |
|
|
2015
Q4 | $310K | Buy |
10,223
+708
| +7% | +$21.5K | ﹤0.01% | 2560 |
|
|
2015
Q3 | $235K | Buy |
9,515
+369
| +4% | +$9.11K | ﹤0.01% | 2696 |
|
|
2015
Q2 | $294K | Sell |
9,146
-4,039
| -31% | -$130K | ﹤0.01% | 2672 |
|
|
2015
Q1 | $471K | Buy |
13,185
+670
| +5% | +$23.9K | ﹤0.01% | 2333 |
|
|
2014
Q4 | $284K | Buy |
12,515
+1,038
| +9% | +$23.6K | ﹤0.01% | 2616 |
|
|
2014
Q3 | $223K | Hold |
11,477
| – | – | ﹤0.01% | 2684 |
|
|
2014
Q2 | $417K | Sell |
11,477
-163
| -1% | -$5.92K | ﹤0.01% | 2392 |
|
|
2014
Q1 | $452K | Sell |
11,640
-384
| -3% | -$14.9K | ﹤0.01% | 2289 |
|
|
2013
Q4 | $343K | Sell |
12,024
-770
| -6% | -$22K | ﹤0.01% | 2505 |
|
|
2013
Q3 | $458K | Sell |
12,794
-78
| -0.6% | -$2.79K | ﹤0.01% | 2268 |
|
|
2013
Q2 | $430K | Buy |
+12,872
| New | +$430K | ﹤0.01% | 2364 |
|